Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone and Renal Safety of Long-term Oral Nucleos(t)ide Analogues in Chronic Hepatitis B
ChiCTR2500111953Phase 4Completed
- Sponsor
- Henan Provincial People's Hospital
- Start
- Nov 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir, tenofovir disoproxil fumarate, tenofovir alafenamide, lamivudine, adefovir dipivoxil and 1 more in Chronic Hepatitis B (CHB) (3 arms), sponsored by Henan Provincial People's Hospital. Primary endpoints: Bone Mineral Density, Bone Markers and 2 more. Started Nov 2025; status: completed.
02
Drugs
entecavirtenofovir disoproxil fumaratetenofovir alafenamidelamivudineadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2500111953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111953.